Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 4
1991 6
1992 3
1993 1
1994 2
1996 1
1997 1
1998 3
1999 2
2000 2
2001 2
2002 1
2003 2
2004 1
2005 2
2006 1
2007 1
2008 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
Heregulin-induced apoptosis.
Le XF, Varela CR, Bast RC Jr. Le XF, et al. Apoptosis. 2002 Dec;7(6):483-91. doi: 10.1023/a:1020682807922. Apoptosis. 2002. PMID: 12370490 Review.
Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma.
Soper JT, Berchuck A, Olt GJ, Soisson AP, Clarke-Pearson DL, Bast RC Jr. Soper JT, et al. Am J Obstet Gynecol. 1990 Oct;163(4 Pt 1):1204-9. doi: 10.1016/0002-9378(90)90692-z. Am J Obstet Gynecol. 1990. PMID: 2220931
Coexpression of different antigenic markers on moieties that bear CA 125 determinants.
Yu YH, Schlossman DM, Harrison CL, Rhinehardt-Clark A, Soper JT, Klug TL, Zurawski VR Jr, Bast RC Jr. Yu YH, et al. Cancer Res. 1991 Jan 15;51(2):468-75. Cancer Res. 1991. PMID: 1702359 Free article.
Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
Bast RC Jr, Knauf S, Epenetos A, Dhokia B, Daly L, Tanner M, Soper J, Creasman W, Gall S, Knapp RC, et al. Bast RC Jr, et al. Cancer. 1991 Oct 15;68(8):1758-63. doi: 10.1002/1097-0142(19911015)68:8<1758::aid-cncr2820680819>;2-#. Cancer. 1991. PMID: 1913520
HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways.
Le XF, Pruefer F, Bast RC Jr. Le XF, et al. Cell Cycle. 2005 Jan;4(1):87-95. doi: 10.4161/cc.4.1.1360. Epub 2005 Jan 10. Cell Cycle. 2005. PMID: 15611642 Review.
Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.
Jacobs IJ, Oram DH, Bast RC Jr. Jacobs IJ, et al. Obstet Gynecol. 1992 Sep;80(3 Pt 1):396-9. Obstet Gynecol. 1992. PMID: 1495694
Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential.
Berchuck A, Soisson AP, Clarke-Pearson DL, Soper JT, Boyer CM, Kinney RB, McCarty KS Jr, Bast RC Jr. Berchuck A, et al. Cancer Res. 1989 Apr 15;49(8):2091-5. Cancer Res. 1989. PMID: 2702650 Free article.
Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers.
Wiener JR, Windham TC, Estrella VC, Parikh NU, Thall PF, Deavers MT, Bast RC, Mills GB, Gallick GE. Wiener JR, et al. Gynecol Oncol. 2003 Jan;88(1):73-9. doi: 10.1006/gyno.2002.6851. Gynecol Oncol. 2003. PMID: 12504632
Differential signaling by an anti-p185(HER2) antibody and heregulin.
Le XF, Vadlamudi R, McWatters A, Bae DS, Mills GB, Kumar R, Bast RC Jr. Le XF, et al. Cancer Res. 2000 Jul 1;60(13):3522-31. Cancer Res. 2000. PMID: 10910064 Free article.
HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy.
Wen XF, Yang G, Mao W, Thornton A, Liu J, Bast RC Jr, Le XF. Wen XF, et al. Oncogene. 2006 Nov 2;25(52):6986-96. doi: 10.1038/sj.onc.1209685. Epub 2006 May 22. Oncogene. 2006. PMID: 16715132
36 results
Jump to page